Susquehanna International Group, LLP Karuna Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $1.7 Million - $3.36 Million	10,575 Added 38.39%	38,118 $12.1 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $12.9 Million - $17.1 Million	-78,240 Reduced 73.96%	27,543 $4.66 Million
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $10.7 Million - $14.5 Million	60,487 Added 133.54%	105,783 $22.9 Million
Q1 2023 May 16, 2023	BUY	$161.33 - $204.36 $4.95 Million - $6.26 Million	30,655 Added 209.38%	45,296 $8.23 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $818,024 - $1.01 Million	-4,271 Reduced 22.58%	14,641 $2.88 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $1.81 Million - $4.06 Million	14,650 Added 343.74%	18,912 $4.25 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $837,084 - $1.28 Million	-8,908 Reduced 67.64%	4,262 $539,000
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $678,750 - $908,455	-6,863 Reduced 34.26%	13,170 $1.67 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $467,232 - $673,146	4,223 Added 26.71%	20,033 $2.62 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $756,267 - $940,626	-7,473 Reduced 32.1%	15,810 $1.93 Million
Q2 2021 Aug 11, 2021	SELL	$107.45 - $135.95 $864,650 - $1.09 Million	-8,047 Reduced 25.68%	23,283 $2.65 Million
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $463,267 - $645,837	-4,853 Reduced 13.41%	31,330 $3.77 Million
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $1.2 Million - $1.74 Million	15,923 Added 78.59%	36,183 $3.68 Million
Q3 2020 Nov 16, 2020	SELL	$71.31 - $109.74 $142,548 - $219,370	-1,999 Reduced 8.98%	20,260 $1.57 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $491,030 - $926,193	7,902 Added 55.04%	22,259 $2.48 Million
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $867,306 - $1.66 Million	14,357 New	14,357 $1.03 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account